$3.460
0.000 (0.00%)收盘时
- High
- 3.460
- Open
- 3.600
- VWAP
- —
- Vol
- 0.00
- Mkt Cap
- 92.95M
- Low
- 3.460
- Amount
- 0.00
- EV/EBITDA, TTM
- 0.00
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Analyst Ratings (1)
估值指标
事件时间线
资讯
9.506-04PRnewswire111, Inc. Reports Q1 2026 Financial Results Highlighting Strategic Transition
2.006-04Newsfilter111 Inc. Reports Q1 2026 Financial Results with Strategic Transition Insights
9.506-04seekingalpha111 Reports Q1 2026 Financial Results
9.504-09NASDAQ.COM111, Inc. Reports Narrower Q4 Net Loss Driven by Lower Expenses
2.004-09PRnewswire111, Inc. Releases Financial Results for Fiscal Year 2025
YI FAQ — answered by Alphio AI
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector (DRUG STORES AND PROPRIETARY STORES industry).
1 analysts cover YI: 1 rate it Buy, 0 Hold and 0 Sell.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。